Clinical Trial: Beta-2-Trace Protein in Diabetic Nephropathy

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919795) titled 'Beta-2-Trace Protein in Diabetic Nephropathy' on Nov. 01.

Brief Summary: This cross-sectional study aims to evaluate serum beta-2-trace protein levels in patients with diabetic nephropathy compared with healthy controls.

Study Start Date: Nov. 10

Study Type: OBSERVATIONAL

Condition: Diabetic Nephropathy Type 2 Type 2 Diabetes Mellitus

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Salma Ramadan Mahmoud Abdelwarth, Assiut University

Disclaimer: Curated by HT Syndication....